Recruiting ISRCTN83479057
This study is recruiting in Australia, in the United Kingdom, in Austria, .... It focuses on schizophrenia.
In Australia Schizophrenia Other From 18 Years to 70 Years
Countries Australia, United Kingdom, Austria, ...
Sponsor University Medical Center Utrecht
Condition Schizophrenia Recruiting ISRCTN77824516
This study is recruiting in Australia. It focuses on Depression.
In Australia Depression Other From 18 Years to 52 Years
Countries Australia
Sponsor Australian Centre for Mental Health Research
Condition Depression Recruiting ISRCTN93903959
This study is recruiting in Australia. It is testing Internet-based interventions for depression.
Remote / online Depression, Anxiety Other Over 18 Years
Countries Australia
Sponsor The Australian National University (Australia)
Condition Depression, Anxiety Recruiting NCT06793397
This study is recruiting in the United States, in Australia, in the United Kingdom, .... It is testing deuterated Psilocin Analog for depression.
In Australia Depression Other From 18 Years to 85 Years
Countries United States, Australia, United Kingdom, ...
Sponsor Cybin IRL Limited
Condition Depression Recruiting ISRCTN85247318
This study is recruiting in Australia. It is testing brain stimulation for ADHD.
In Australia ADHD Other From 18 Years to 35 Years
Countries Australia
Sponsor Neurode Labs Pty. Ltd.
Condition ADHD Recruiting NCT07412756
This study is recruiting in the United States, in Australia, in Canada, .... It is testing brenipatide for depression.
In Australia Depression Other From 18 Years to 75 Years
Countries United States, Australia, Canada, ...
Sponsor Eli Lilly and Company
Condition Depression Recruiting NCT06524830
This study is recruiting in the United States, in Australia, in Canada, .... It is testing VLS-01 Buccal Film, Compared to Placebo for treatment-resistant depression.
In Australia Depression Other From 18 Years to 65 Years
Countries United States, Australia, Canada, ...
Sponsor atai Therapeutics, Inc.
Condition Depression Recruiting NCT06929273
This study is recruiting in the United States, in Australia, in France, .... It is testing KarXT for manic episodes in bipolarity type I.
In Australia Bipolarity Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries United States, Australia, France, ...
Sponsor Bristol-Myers Squibb
Condition Bipolarity Recruiting NCT06947941
This study is recruiting in the United States, in Australia, in Canada, .... It is testing Safety and Efficacy of KarXT + KarX-EC for Schizophrenia.
In Australia Schizophrenia Other From 55 Years to 90 Years
Countries United States, Australia, Canada, ...
Sponsor Bristol-Myers Squibb
Condition Schizophrenia Recruiting NCT06951698
This study is recruiting in the United States, in Australia, in New Zealand, .... It is testing KarXT for manic episodes in bipolarity type I.
In Australia Bipolarity Drug From 18 Years to 65 Years
Countries United States, Australia, New Zealand, ...
Sponsor Bristol-Myers Squibb
Condition Bipolarity Recruiting NCT07196501
This study is recruiting in the United States, in Australia, in Canada, .... It is testing Maintenance Effect of NBI-1065845 for depression.
In Australia Depression Other Over 18 Years
Countries United States, Australia, Canada, ...
Sponsor Neurocrine Biosciences
Condition Depression Recruiting ISRCTN85462326
This study is recruiting. It focuses on anxiety and currently lists participation information in the United Kingdom and Australia.
In Australia Anxiety Other From 60 Years to 100 Years
Countries Australia, United Kingdom
Sponsor Camden and Islington NHS Foundation Trust
Condition Anxiety